WallStSmart

Medirom Healthcare Technologies Inc (MRM)vsService Corporation International (SCI)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Medirom Healthcare Technologies Inc generates 86% more annual revenue ($8.07B vs $4.33B). SCI leads profitability with a 12.4% profit margin vs 0.5%. MRM trades at a lower P/E of 3.0x. SCI earns a higher WallStSmart Score of 56/100 (C).

MRM

Hold

39

out of 100

Grade: F

Growth: 4.0Profit: 4.5Value: 8.3Quality: 4.0
Piotroski: 3/9Altman Z: 0.93

SCI

Buy

56

out of 100

Grade: C

Growth: 3.3Profit: 7.5Value: 5.0Quality: 3.0
Piotroski: 4/9Altman Z: 0.48
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MRMUndervalued (+62.4%)

Margin of Safety

+62.4%

Fair Value

$3.46

Current Price

$1.13

$2.33 discount

UndervaluedFair: $3.46Overvalued

Intrinsic value data unavailable for SCI.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MRM3 strengths · Avg: 9.3/10
P/E RatioValuation
3.0x10/10

Attractively priced relative to earnings

Return on EquityProfitability
63.9%10/10

Every $100 of equity generates 64 in profit

EPS GrowthGrowth
27.8%8/10

Earnings expanding 27.8% YoY

SCI2 strengths · Avg: 9.0/10
Return on EquityProfitability
39.5%10/10

Every $100 of equity generates 40 in profit

Operating MarginProfitability
22.1%8/10

Strong operational efficiency at 22.1%

Areas to Watch

MRM4 concerns · Avg: 3.0/10
Market CapQuality
$8.93M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.5%3/10

0.5% margin — thin

Debt/EquityHealth
1.753/10

Elevated debt levels

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

SCI4 concerns · Avg: 3.0/10
PEG RatioValuation
1.514/10

Expensive relative to growth rate

Revenue GrowthGrowth
2.1%4/10

2.1% revenue growth

EPS GrowthGrowth
-1.0%2/10

Earnings declined 1.0%

Altman Z-ScoreHealth
0.482/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : MRM

The strongest argument for MRM centers on P/E Ratio, Return on Equity, EPS Growth.

Bull Case : SCI

The strongest argument for SCI centers on Return on Equity, Operating Margin.

Bear Case : MRM

The primary concerns for MRM are Market Cap, Profit Margin, Debt/Equity. Debt-to-equity of 1.75 is elevated, increasing financial risk. Thin 0.5% margins leave little buffer for downturns.

Bear Case : SCI

The primary concerns for SCI are PEG Ratio, Revenue Growth, EPS Growth. Debt-to-equity of 3.26 is elevated, increasing financial risk.

Key Dynamics to Monitor

MRM carries more volatility with a beta of 1.00 — expect wider price swings.

SCI is growing revenue faster at 2.1% — sustainability is the question.

SCI generates stronger free cash flow (254M), providing more financial flexibility.

Monitor PERSONAL SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

SCI scores higher overall (56/100 vs 39/100). MRM offers better value entry with a 62.4% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Medirom Healthcare Technologies Inc

CONSUMER CYCLICAL · PERSONAL SERVICES · USA

MEDIROM Healthcare Technologies Inc. provides comprehensive healthcare services in Japan. The company is headquartered in Tokyo, Japan.

Visit Website →

Service Corporation International

CONSUMER CYCLICAL · PERSONAL SERVICES · USA

Service Corporation International offers death care products and services in the United States and Canada. The company is headquartered in Houston, Texas.

Want to dig deeper into these stocks?